Yield10 Bioscience

Yield10 Bioscience Revenue

The The revenue of Yield10 Bioscience (YTENQ) as of Nov 21, 2026 is 60,000.00 USD. In the previous year, The revenue was 450,000.00 USD — a change of -86.67% (lower).

Revenue

60,000.00USD

YoY

-86.67%

Last updated:

In 2023, Yield10 Bioscience's sales reached 60,000.00 USD, a -86.67% difference from the 450,000.00 USD sales recorded in the previous year.

Revenue at Yield10 Bioscience has contracted by 19.5% per year over the past 19 years to 60,000.00 USD.

The Yield10 Bioscience Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2019
810,000.00 USD
Jan 1, 2020
799,000.00 USD
Jan 1, 2021
614,000.00 USD
Jan 1, 2022
450,000.00 USD
Jan 1, 2023
60,000.00 USD
Jan 1, 2024 (e)
0.00 USD
Jan 1, 2025 (e)
1.24 M USD
Jan 1, 2026 (e)
27.55 M USD
The Yield10 Bioscience Revenue history
YEARRevenueYoY
est27.55 MUSD+2,129.21%
est1.24 MUSD—
est0.00USD-100.00%
60,000.00USD-86.67%
450,000.00USD-26.71%
614,000.00USD-23.15%
799,000.00USD-1.36%
810,000.00USD+44.64%
560,000.00USD-40.43%
940,000.00USD-18.97%
1.16 MUSD-14.07%
1.35 MUSD-51.79%
2.80 MUSD-25.93%
3.78 MUSD-90.87%
41.38 MUSD+2,793.71%
1.43 MUSD+217.78%
450,000.00USD-68.53%
1.43 MUSD-8.33%
1.56 MUSD-7.14%
1.68 MUSD-63.40%
4.59 MUSD+65.11%
2.78 MUSD-24.46%
3.68 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yield10 Bioscience Revenue

Yield10 Bioscience Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
810,000.00 USD
-8.59 M USD
-12.96 M USD
Jan 1, 2020
799,000.00 USD
-9.61 M USD
-10.21 M USD
Jan 1, 2021
614,000.00 USD
-11.69 M USD
-11.03 M USD
Jan 1, 2022
450,000.00 USD
-13.45 M USD
-13.57 M USD
Jan 1, 2023
60,000.00 USD
-14.42 M USD
-14.46 M USD
Jan 1, 2024 (e)
0.00 USD
-9.68 M USD
-7.66 M USD
Jan 1, 2025 (e)
1.24 M USD
-10.23 M USD
-1.96 M USD
Jan 1, 2026 (e)
27.55 M USD
-6.34 M USD
-99,498.00 USD

Yield10 Bioscience Margins

Yield10 Bioscience stock margins

The Yield10 Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Yield10 Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Yield10 Bioscience.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
47.14 %
-1,060.49 %
-1,600.00 %
Jan 1, 2020
47.14 %
-1,202.63 %
-1,277.35 %
Jan 1, 2021
47.14 %
-1,904.23 %
-1,796.58 %
Jan 1, 2022
47.14 %
-2,989.11 %
-3,014.67 %
Jan 1, 2023
47.14 %
-24,028.33 %
-24,091.67 %
Jan 1, 2024 (e)
47.14 %
- %
- %
Jan 1, 2025 (e)
47.14 %
-827.58 %
-158.70 %
Jan 1, 2026 (e)
47.14 %
-23.01 %
-0.36 %

Yield10 Bioscience Stock analysis

What does Yield10 Bioscience do? Yield10 Bioscience develops Camelina sativa as a platform crop for low carbon sustainable seed products, including Camelina oil for biofuel feedstock, Omega-3 oils for nutrition, and PHA Bioplastics for biodegradable packaging. The company uses its TraitFactory platform to discover genetic traits for agriculture and food industries, focusing on herbicide tolerance and disease resistance in Camelina germplasm. Its products target petroleum replacement markets, food and nutrition sectors, and animal feed markets, with development pipelines focused on improving Camelina varieties. The company's primary products are Camelina oil, Omega-3 oils, and PHA Bioplastics, sold to markets addressing petroleum replacement, nutrition, and sustainable packaging needs. Camelina sativa serves as the core crop for all seed product development, with TraitFactory enabling trait discovery for agricultural and food applications. The firm targets industrial buyers in biofuel, nutrition, and packaging industries seeking sustainable alternatives to petroleum-based products. Yield10 Bioscience's revenue streams come from the sale of Camelina-based products to companies in the biofuel, nutrition, and packaging sectors. The company focuses on developing high-value genetic traits through TraitFactory, which are integrated into Camelina varieties for large-scale production of seed products. Its development pipeline emphasizes traits like herbicide tolerance and disease resistance to enhance crop performance and market appeal. Yield10 Bioscience is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Yield10 Bioscience's Sales Figures

The sales figures of Yield10 Bioscience originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Yield10 Bioscience’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Yield10 Bioscience's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Yield10 Bioscience’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Yield10 Bioscience stock

The revenue of Yield10 Bioscience is 60,000.00 USD in 2023.

The revenue of Yield10 Bioscience changed from 450,000.00 USD to 60,000.00 USD, representing a -86.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The revenue Yield10 Bioscience since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Yield10 Bioscience historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Yield10 Bioscience

All Key Metrics — Yield10 Bioscience